TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 97 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2015. The put-call ratio across all filers is 0.54 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $242,426 | -11.8% | 8,348 | -9.1% | 0.00% | 0.0% |
Q3 2022 | $275,000 | -26.5% | 9,183 | -11.4% | 0.00% | 0.0% |
Q2 2022 | $374,000 | -33.8% | 10,361 | +12.3% | 0.00% | -83.3% |
Q1 2020 | $565,000 | -81.0% | 9,224 | -76.6% | 0.01% | -73.9% |
Q3 2019 | $2,975,000 | +334.3% | 39,432 | +392.0% | 0.02% | +283.3% |
Q2 2019 | $685,000 | -50.3% | 8,014 | -42.8% | 0.01% | 0.0% |
Q3 2018 | $1,378,000 | +66.2% | 14,014 | +142.2% | 0.01% | -25.0% |
Q1 2016 | $829,000 | -83.1% | 5,787 | -81.8% | 0.01% | -82.6% |
Q4 2015 | $4,911,000 | +16.7% | 31,779 | +7.9% | 0.05% | -11.5% |
Q3 2015 | $4,209,000 | -36.8% | 29,457 | -36.5% | 0.05% | -40.2% |
Q2 2015 | $6,665,000 | +27.6% | 46,383 | +25.3% | 0.09% | +27.9% |
Q1 2015 | $5,222,000 | -63.7% | 37,029 | -61.8% | 0.07% | -64.2% |
Q4 2014 | $14,377,000 | +182.1% | 97,017 | +192.9% | 0.19% | +156.8% |
Q3 2014 | $5,097,000 | +226.9% | 33,128 | +198.0% | 0.07% | +221.7% |
Q2 2014 | $1,559,000 | – | 11,116 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |